Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.Through our Genome5000™ program, Lexicon scientists spent more than a decade studying the role and function of nearly 5,000 genes to pinpoint the key targets for drug development.
|Bank Name||Lexicon Pharmaceuticals, Inc.|
|CEO||Mr. Lonnel Coats|